Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
[PDF][PDF] Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
M Ruiz, M Jové, A Schlüter, C Casasnovas… - Human Molecular …, 2015 - academia.edu
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
[引用][C] Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
M Ruiz, M Jové Font, A Schlüter, C Casasnovas… - 2015 - repositori.udl.cat
Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
M Ruiz, M Jové, A Schlüter… - Human molecular …, 2015 - pubmed.ncbi.nlm.nih.gov
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
[PDF][PDF] Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
M Ruiz, M Jové, A Schlüter… - Human Molecular …, 2015 - scholar.archive.org
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
[PDF][PDF] Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
M Ruiz, M Jové, A Schlüter, C Casasnovas… - Human Molecular …, 2015 - researchgate.net
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy.
M Ruiz, M Jové, A Schlüter, C Casasnovas… - Human Molecular …, 2015 - europepmc.org
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
onAltered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy.
M Ruiz, M Jové, A Schlüter… - Human Molecular …, 2015 - search.ebscohost.com
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
[PDF][PDF] Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
M Ruiz, M Jové, A Schlüter, C Casasnovas… - Human Molecular …, 2015 - academia.edu
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
[引用][C] Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
M Ruiz, M Jové Font, A Schlüter, C Casasnovas… - 2015 - repositori.udl.cat